DOXYCYCLINE HYCLATE TABLETS

The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7590 for the supply of Doxycycline Hyclate Tablets identified by NSN 6505016003042 and NDC NDC62135-0626-01, with a total contract value of $5.55 for one bulk tablet unit. The award was issued on July 14, 2026, and delivery is required by July 29, 2026, to Fort Stewart, Georgia, under FOB destination terms, with the contractor responsible for all transportation costs and ensuring shipment via the fastest traceable means, explicitly prohibiting parcel post. Packaging and labeling requirements mandate the inclusion of the Transportation Control Number W33RBS61940107, Required Delivery Date 206, NSN, CAGE code 8APGO, and part number on the shipment, though specific packaging standards or MIL-STD references are not formally cited. Inspection and acceptance occur at the delivery location, and while the item is subject to federal pharmaceutical procurement protocols, explicit adherence to FDA, USP, or military specifications is not detailed in the contract. Payment is tied to the FOB contractor method, with the Defense Agencies Indexing Code A0A and Procurement Request 7017498945 used for accounting, though no remittance or invoicing platform details are provided. The contracting office is listed as DLA under code 97AS, but no Contracting Officer, COR, or COTR contact information is included, and no formal FAR clauses, Section K certifications, or evaluation factors are documented. The contract lacks option periods, multiple CLINs, or socioeconomic representations, suggesting a direct, low-value award executed under a Low-Price Technically Acceptable approach without competition documentation or trade-off analysis.